Travis D Westbrook1, Kami Maddocks2, Barbara L Andersen1. 1. a Department of Psychology , The Ohio State University , Columbus , OH , USA. 2. b Division of Hematology , The Ohio State University Wexner Medical Center , Columbus , OH , USA.
Abstract
OBJECTIVE: Chronic lymphocytic leukaemia (CLL) is the most prevalent adult leukaemia and is incurable. The course and treatment of CLL is unique and characterised by repeated cycles of treatment, stable disease and relapse. Utilising a Self-Regulatory Model framework, we examined the relationship between patients' illness perceptions and cancer-specific stress, depressive symptoms and fatigue. Our aim was to test illness perceptions as predictors of these outcomes when variance due to disease and treatment variables was controlled. DESIGN: Data were collected on 147 patients with relapsed/refractory CLL as they entered a phase II clinical trial of an investigational medication at a university affiliated, National Cancer Institute designated comprehensive cancer center. MAIN OUTCOME MEASURES: Cancer-specific stress, depressive symptoms and fatigue interference. RESULT: . Hierarchical multiple regression was used. Consequences and emotional representation were related to all outcomes (ps < .01). Illness concern was related to cancer-specific stress (p < .01), and identity was related to fatigue interference (p < .01). All relationships were observed while controlling for number of previous CLL therapies received. CONCLUSION: Illness perceptions are related to cancer-specific stress, depressive symptoms and fatigue interference in relapsed/refractory CLL. Interventions targeted at restructuring maladaptive illness perceptions may have clinical benefit in this population.
OBJECTIVE:Chronic lymphocytic leukaemia (CLL) is the most prevalent adult leukaemia and is incurable. The course and treatment of CLL is unique and characterised by repeated cycles of treatment, stable disease and relapse. Utilising a Self-Regulatory Model framework, we examined the relationship between patients' illness perceptions and cancer-specific stress, depressive symptoms and fatigue. Our aim was to test illness perceptions as predictors of these outcomes when variance due to disease and treatment variables was controlled. DESIGN: Data were collected on 147 patients with relapsed/refractory CLL as they entered a phase II clinical trial of an investigational medication at a university affiliated, National Cancer Institute designated comprehensive cancer center. MAIN OUTCOME MEASURES: Cancer-specific stress, depressive symptoms and fatigue interference. RESULT: . Hierarchical multiple regression was used. Consequences and emotional representation were related to all outcomes (ps < .01). Illness concern was related to cancer-specific stress (p < .01), and identity was related to fatigue interference (p < .01). All relationships were observed while controlling for number of previous CLL therapies received. CONCLUSION: Illness perceptions are related to cancer-specific stress, depressive symptoms and fatigue interference in relapsed/refractory CLL. Interventions targeted at restructuring maladaptive illness perceptions may have clinical benefit in this population.
Authors: Barbara L Andersen; Charles L Shapiro; William B Farrar; Timothy Crespin; Sharla Wells-Digregorio Journal: Cancer Date: 2005-10-01 Impact factor: 6.860
Authors: Jan A Burger; Michael J Keating; William G Wierda; Elena Hartmann; Julia Hoellenriegel; Nathalie Y Rosin; Iris de Weerdt; Ghayathri Jeyakumar; Alessandra Ferrajoli; Marylou Cardenas-Turanzas; Susan Lerner; Jeffrey L Jorgensen; Graciela M Nogueras-González; Gracy Zacharian; Xuelin Huang; Hagop Kantarjian; Naveen Garg; Andreas Rosenwald; Susan O'Brien Journal: Lancet Oncol Date: 2014-08-20 Impact factor: 41.316
Authors: Nicola M Gray; Susan J Hall; Susan Browne; Marie Johnston; Amanda J Lee; Una Macleod; Elizabeth D Mitchell; Leslie Samuel; Neil C Campbell Journal: Support Care Cancer Date: 2014-02 Impact factor: 3.603
Authors: Esther C van den Broek; Simone Oerlemans; Marten R Nijziel; Eduardus F M Posthuma; Jan Willem W Coebergh; Lonneke V van de Poll-Franse Journal: Ann Hematol Date: 2014-07-20 Impact factor: 3.673
Authors: Tait D Shanafelt; Deborah A Bowen; Chaya Venkat; Susan L Slager; Clive S Zent; Neil E Kay; Megan Reinalda; Han Tun; Jeff A Sloan; Timothy G Call Journal: Leuk Res Date: 2008-07-25 Impact factor: 3.156
Authors: Sharon A Cook; Peter Salmon; Graham Dunn; Chris Holcombe; Philip Cornford; Peter Fisher Journal: Health Psychol Date: 2014-08-18 Impact factor: 4.267
Authors: Masoumeh Pourfallahi; Mohammad Gholami; Mohammad Javad Tarrahi; Tahereh Toulabi; Parastou Kordestani Moghadam Journal: Support Care Cancer Date: 2019-05-07 Impact factor: 3.603
Authors: Travis D Westbrook; Eleshia J Morrison; Kami J Maddocks; Farrukh T Awan; Jeffrey A Jones; Jennifer A Woyach; Amy J Johnson; John C Byrd; Barbara L Andersen Journal: Ann Behav Med Date: 2019-08-16
Authors: Melanie P J Schellekens; Marije D J Wolvers; Maya J Schroevers; Tom I Bootsma; Angélique O J Cramer; Marije L van der Lee Journal: J Behav Med Date: 2019-08-22
Authors: David Dias Neto; Ana Nunes da Silva; Magda Sofia Roberto; Jelena Lubenko; Marios Constantinou; Christiana Nicolaou; Demetris Lamnisos; Savvas Papacostas; Stefan Höfer; Giovambattista Presti; Valeria Squatrito; Vasilis S Vasiliou; Louise McHugh; Jean-Louis Monestès; Adriana Baban; Javier Alvarez-Galvez; Marisa Paez-Blarrina; Francisco Montesinos; Sonsoles Valdivia-Salas; Dorottya Ori; Raimo Lappalainen; Bartosz Kleszcz; Andrew Gloster; Maria Karekla; Angelos P Kassianos Journal: Front Psychol Date: 2021-04-14